2-nitroimidazole-1-methylacetohydroxamate has been researched along with ku 2285 in 1 studies
Studies (2-nitroimidazole-1-methylacetohydroxamate) | Trials (2-nitroimidazole-1-methylacetohydroxamate) | Recent Studies (post-2010) (2-nitroimidazole-1-methylacetohydroxamate) | Studies (ku 2285) | Trials (ku 2285) | Recent Studies (post-2010) (ku 2285) |
---|---|---|---|---|---|
8 | 0 | 0 | 19 | 2 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, M; Iwai, H; Murata, R; Oya, N; Shibamoto, Y; Shibata, T; Sugiyama, T | 1 |
1 other study(ies) available for 2-nitroimidazole-1-methylacetohydroxamate and ku 2285
Article | Year |
---|---|
KIN-804 vs. KU-2285 as a radiosensitizer for clinical use.
Topics: Animals; Carcinoma, Squamous Cell; Chromosome Aberrations; Female; Humans; Hydroxamic Acids; Mice; Mice, Inbred C3H; Micronucleus Tests; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents | 1994 |